OncoSec Medical Incorporated

OncoSec Medical Incorporated

ONCSQ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$60
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
OncoSec Medical IncorporatedOncoSec Medical Incorporated0-549%--0.6

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$60.00
Enterprise Value$-219,057.00
Earnings per Share$-19.13
Beta9.37
Outstanding Shares25,873

Return

Return on Equity549.36%ROE
Return on Assets-339.76%
Return on Invested Capital-1990.76%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.01
Enterprise Value to Net Income0
Total Debt to Enterprise-15.81
Debt to Equity-0.63Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 23, 2026
EPS Estimate
-$6.75
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
December 11, 2026
EPS Estimate
-$8.90
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About OncoSec Medical Inc

40 employees
CEO: Daniel O'Connor

OncoSec Medical Incorporated was an immuno-oncology firm focused on the advanced stages of drug development. Its primary mission involved devising, perfecting, and bringing to market DNA-based treatments administered directly into tumors...